Market Pulse Archives

May 11, 2022, 4:33 p.m. EDT

SPDR S&P Biotech ETF closed Monday at a five-year low

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    SPDR S&P Biotech ETF (XBI)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

The SPDR S&P Biotech ETF /zigman2/quotes/205950134/composite XBI +1.09% closed at a five-year low of $64.37 on Monday as U.S. stocks plunged on concerns about continued inflation and the threat of weaker growth. The last time the price for the biotech ETF was down this low was in December 2018. "A combination of clinical and regulatory setbacks, lack of M&A, and macro environment has created a downward spiral that appears to us to be an excessive overreaction to the 2020- to early-'21 'bubble,'" RBC Capital Markets analyst Brian Abrahams told investors on Tuesday. The SPDR S&P Biotech ETF has tumbled 37.3% this year, while the broader S&P 500 /zigman2/quotes/210599714/realtime SPX +3.06% is down 16.2%.

US : U.S.: NYSE Arca
$ 77.06
+0.83 +1.09%
Volume: 18.56M
June 24, 2022 4:00p
+116.01 +3.06%
Volume: 3.46B
June 24, 2022 5:05p

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.